The quirks and quarks of keeping the Vancouver biotech ecosystem afloat
Quark Venture, a venture capital (VC) fund launched in 2016, has followed through with its promise of investing in prominent Vancouver biotech companies. The US$500-million fund — the largest of its kind in Canada — is expected to have a significant impact in the biotech industry both locally and nationwide.
(...) While the arrival of Quark Venture brings new opportunities to the biotechnology industry, will its investments help improve the longevity of biotech firms in Vancouver?